Prostate Cancer and Prostatic Diseases
Collection
Collection
- ISSN: 13657852
Published by Nature Publishing Group NPG (MacMillan)
-
Greater influence of age than co-morbidity on primary treatment and complications of prostate cancer patients: An in-depth population-based study Article
Prostate Cancer and Prostatic Diseases, 9(2), 179-184.S. Houterman (Saskia), M.L.G. Janssen-Heijnen (Maryska), C.D.G.W. Verheij (C. D G W), P.J.M. Kil (Paul), H.A. van den Berg (Hetty) and J.W.W. Coebergh (Jan Willem)
June 2006 -
Very late local recurrence after surgery for prostate cancer unaccompanied by detectable PSA levels Article
Prostate Cancer and Prostatic Diseases, 9(2), 192-194.S. Roemeling (Stijn), G.J.H.L. Leenders (Geert) and F.H. Schröder (Fritz)
June 2006 -
The relationship of body mass index and serum testosterone with disease outcomes in men with castration-resistant metastatic prostate cancer Article
Prostate Cancer and Prostatic Diseases, 12(1), 88-93.A.J. Armstrong (Andrew), S. Halabi (Susan), R. de Wit (Ronald), I.F. Tannock (Ian) and M.A. Eisenberger (Mario)
January 2009 -
The implementation of screening for prostate cancer Review
P.J. van Leeuwen (Pim), H.A. van Vugt (Heidi) and C.H. Bangma (Chris)
September 2010 -
Daily, monthly and seasonal variation in PSA levels and the association with weather parameters Article
Prostate Cancer and Prostatic Diseases, 14(1), 58-62.D. Connolly, P.J. van Leeuwen (Pim), J. Bailie, A. Black, L. Murray, P.F. Keane (Patrick) and A.T. Gavin (Anna)
March 2011 -
Multidrug and toxin extrusion 1 and human organic cation transporter 1 polymorphisms in patients with castration-resistant prostate cancer receiving metformin (SAKK 08/09) Article
Prostate Cancer and Prostatic Diseases, 18(2), 167-172.M. Joerger, R.H.N. van Schaik (Ron), M.L. Becker, S. Hayoz, M. Pollak, R. Cathomas (Richard), R. Winterhalder, S. Gillessen and C. Rothermundt
June 2015 -
Adaptation and external validation of the European randomised study of screening for prostate cancer risk calculator for the Chinese population Article
Prostate Cancer and Prostatic Diseases, 20(1), 99-104.Peter Ka-Fung Chiu (K.F.), M.J. Roobol-Bouts (Monique), D. Nieboer (Daan), Teoh, J.Y. (J. Y.), Yuen, S.K. (S. K.), Hou, S.M. (S. M.), Yiu, M.K. (M. K.) and Ng, C.F. (C. F.)
March 2017 -
Immediate treatment vs. active-surveillance in very-low-risk prostate cancer The role of patient-, tumour-, and hospital-related factors Article
Prostate Cancer and Prostatic DiseasesJansen, H. (Hanneke), I.M. van Oort (Inge), G. van Andel (George), Wijsman, B.P. (Bart P.), F.J. Pos (Floris), M.C.C.M. Hulshof (Maarten), C.A. Hulsbergen-van de Kaa (Christina), G.J.H.L. Leenders (Geert), J. Fütterer (Jurgen), D.M. Somford (Diederik), et al. M. Busstra (Martijn), R.J.A. van Moorselaar, Kiemeney, L.A. (Lambertus A.) and K.K.H. Aben (Katja)
November 2018